Literature DB >> 15929861

Free fatty acids and insulin secretion in humans.

Guenther Boden1.   

Abstract

Acute increases in plasma levels of long-chain fatty acids raise plasma insulin levels by stimulating insulin secretion or by decreasing insulin clearance. In normal subjects, long-term elevations of fatty acids also stimulate insulin secretion. In fact, they increase insulin precisely to the degree needed to compensate for the fatty acid-induced insulin resistance. In contrast, in individuals who are genetically predisposed to develop type 2 diabetes (prediabetic subjects), the free fatty acid (FFA) stimulation of insulin secretion is not sufficient to fully compensate for the FFA-induced insulin resistance. Therefore, obesity, if associated with elevated fatty acid levels, may lead to hyperglycemia in prediabetic but not in normal individuals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929861     DOI: 10.1007/s11892-005-0004-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  23 in total

1.  Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin.

Authors:  R Pelkonen; T A Miettinen; M R Taskinen; E A Nikkilä
Journal:  Diabetes       Date:  1968-02       Impact factor: 9.461

2.  A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.

Authors:  Y Sako; V E Grill
Journal:  Endocrinology       Date:  1990-10       Impact factor: 4.736

3.  Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.

Authors:  G Boden; X Chen
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

4.  Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

Authors:  A T Santomauro; G Boden; M E Silva; D M Rocha; R F Santos; M J Ursich; P G Strassmann; B L Wajchenberg
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

5.  Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention.

Authors:  Stephanie M Benjamin; Rodolfo Valdez; Linda S Geiss; Deborah B Rolka; K M Venkat Narayan
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

6.  Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect.

Authors:  S R Crespin; W B Greenough; D Steinberg
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

7.  Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men.

Authors:  Christine B Jensen; Heidi Storgaard; Jens J Holst; Flemming Dela; Sten Madsbad; Allan A Vaag
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.

Authors:  G Boden; J S Soeldner; R E Gleason; A Marble
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

9.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.

Authors:  Y P Zhou; V E Grill
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

Authors:  W Pimenta; M Korytkowski; A Mitrakou; T Jenssen; H Yki-Jarvinen; W Evron; G Dailey; J Gerich
Journal:  JAMA       Date:  1995-06-21       Impact factor: 56.272

View more
  25 in total

Review 1.  Mechanisms of insulin resistance in obesity.

Authors:  Jianping Ye
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

Review 2.  Mitochondrially derived peptides as novel regulators of metabolism.

Authors:  Su-Jeong Kim; Jialin Xiao; Junxiang Wan; Pinchas Cohen; Kelvin Yen
Journal:  J Physiol       Date:  2017-07-18       Impact factor: 5.182

Review 3.  Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes.

Authors:  Ming Lu; Changhong Li
Journal:  Ann N Y Acad Sci       Date:  2017-10-16       Impact factor: 5.691

Review 4.  Metabolic actions of insulin in men and women.

Authors:  Faidon Magkos; Xuewen Wang; Bettina Mittendorfer
Journal:  Nutrition       Date:  2010-04-14       Impact factor: 4.008

5.  Etiology, Treatment and Prevention of Obesity in Childhood and Adolescence: A Decade in Review.

Authors:  Donna Spruijt-Metz
Journal:  J Res Adolesc       Date:  2011-03

6.  Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.

Authors:  Dale S Edgerton; Guillaume Kraft; Marta Smith; Ben Farmer; Phillip E Williams; Katie C Coate; Richard L Printz; Richard M O'Brien; Alan D Cherrington
Journal:  JCI Insight       Date:  2017-03-23

7.  Multidirectional time-dependent effect of sinigrin and allyl isothiocyanate on metabolic parameters in rats.

Authors:  Monika Okulicz
Journal:  Plant Foods Hum Nutr       Date:  2010-09       Impact factor: 3.921

8.  Elevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation during diet-induced insulin resistance in dogs.

Authors:  Josiane L Broussard; Cathryn M Kolka; Ana V B Castro; Isaac Asare Bediako; Rebecca L Paszkiewicz; Edward W Szczepaniak; Lidia S Szczepaniak; Kristen L Knutson; Stella P Kim; Richard N Bergman
Journal:  Diabetologia       Date:  2015-08-09       Impact factor: 10.122

9.  Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice.

Authors:  Sunhyo Jeong; Michung Yoon
Journal:  Exp Mol Med       Date:  2009-06-30       Impact factor: 8.718

Review 10.  Obesity and free fatty acids.

Authors:  Guenther Boden
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.